Cascadia Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$892K Buy
11,870
+325
+3% +$24.7K 0.18% 127
2021
Q2
$898K Buy
11,545
+571
+5% +$42.5K 0.19% 127
2021
Q1
$807K Buy
+10,974
New +$809K 0.18% 132
2020
Q3
$1.09M Sell
13,828
-17,380
-56% -$1.36M 0.31% 94
2020
Q2
$2.3M Buy
+31,208
New +$2.35M 0.7% 33
2019
Q4
$681K Buy
+7,852
New +$645K 0.19% 121

Other funds holding MRK

Cascadia Advisory Services's MRK Position: Q3 2021 in Review

Cascadia Advisory Services increased its Merck (MRK) stake by 2.8% in Q3 2021, buying an estimated $24.7K and bringing the position to 11,870 shares worth $892K. The position accounts for 0.18% of the portfolio, ranked #127.

Cascadia Advisory Services first reported a position in MRK in Q4 2019 and has held it in 6 quarters since. The position peaked at $2.3M in Q2 2020. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Cascadia Advisory Services held 11,870 shares of Merck worth $892K as of Q3 2021.
  • Cascadia Advisory Services bought 325 Merck shares in Q3 2021, an estimated $24.7K.
  • Merck made up 0.18% of Cascadia Advisory Services's portfolio in Q3 2021, its #127 holding.
  • Cascadia Advisory Services first reported a position in Merck in Q4 2019 and has held it in 6 quarters since.
  • Cascadia Advisory Services's Merck position peaked at $2.3M in Q2 2020.
  • 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Cascadia Advisory Services's 13F filing for Q3 2021, filed 12 Nov 2021.